The SLEek Study

from ACR Journals On Air · host The American College of Rheumatology

This week, our next guest, ACR Master Dr. Joan T. Merrill, joins us to discuss her latest study which endeavored to evaluate the efficacy and safety of upadacitinib and elsubrutinib in those with systemic lupus erythematosus (SLE). Join us for an in-depth analysis of the SLEek Study, its findings regarding the efficacy of these medications and Dr. Merrill's conclusions.

Episode metadata supplied by the publisher feed · Published Oct 15, 2024

Embed this episode

Attribution link and audio player

Ready to play

The SLEek Study

0:00 42:40

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of ACR Journals On Air?

This episode is 42 minutes long.

When was this ACR Journals On Air episode published?

This episode was published on October 15, 2024.

Can I download this ACR Journals On Air episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!